Erratum to: Heart-protective effect of n-3 PUFA demonstrated in a rat model of diabetic cardiomyopathy (Molecular and Cellular Biochemistry (2014) 389 (219-227) DOI: 10.1007/s11010-013-1943-9);Heart-protective effect of n-3 PUFA demonstrated in a rat model of diabetic cardiomyopathy

Molecular and Cellular Biochemistry

Volumn 389, Issue 1-2, 2014, Pages 219-227

  Anna, Zhukovska ^a   Angela, Shysh ^a   Barbara, Bacova ^b   Jana, Radosinska ^c   Tamara, Benova ^b   Csilla, Viczenczova ^b   Victor, Dosenko ^a   Oleksiy, Moybenko ^a   Narcisa, Tribulova ^b  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c Physics and Informatics   (Slovakia)

Author keywords

Connexin 43; Diabetes; n 3 PUFA; Rat heart function

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; CONNEXIN 43; GLUCOSE; MESSENGER RNA; MYOSIN HEAVY CHAIN BETA; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY COMPLIANCE; ARTICLE; BODY WEIGHT; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; FAT INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CELL; HEART OUTPUT; HEART PROTECTION; HEART RIGHT VENTRICLE ENDSYSTOLIC PRESSURE; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART WEIGHT; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

RATTUS;

ANIMALS; CARDIAC OUTPUT; CONNEXIN 43; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; FATTY ACIDS, OMEGA-3; HEART; MALE; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-1; RNA, MESSENGER; STREPTOZOCIN;

EID: 84896544561     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2026-2     Document Type: Erratum

References (37)

1. Khavandi K, Khavandi A, Asghar O, Greenstein A, Withers S, Heagerty AM, Malik RA (2009) Diabetic cardiomyopathy - a distinct disease? Best Pract Res Clin Endocrinol Metab 23:347-360
2. Boudina S, Abel ED (2010) Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11:31-39
3. Dhalla NS, Rangi S, Zieroth S, Xu YJ (2012) Alterations in sarcoplasmic reticulum and mitochondrialfunctions in diabetic cardiomyopathy. Exp Clin Cardiol 17:115-120
4. Ferko M, Gvozdjaková A, Kucharská J, Mujkosová J, Waczulíková I, Styk J, Ravingerová T, Ziegelhöffer- Mihalovicová B, Ziegelhöffer A (2006) Functional remodeling of heart mitochondria in acute diabetes: interrelationships between damage, endogenous protection and adaptation. Gen Physiol Biophys 25:397-413 (Pubitemid 46420936)
5. Shimoni Y, Emmett T, Schmidt R, Nygren A, Kargacin G (2009) Sexdependent impairment of cardiac action potential conduction in type 1 diabetic rats. Am J Physiol HeartCirc Physiol 296:1442-1450
6. Lin H, Ogawa K, Imanaga I, Tribulova N (2006) Remodeling of connexin 43 in the diabetic rat heart. Mol Cell Biochem 290: 69-78 (Pubitemid 44473236)
7. Lin H, Mitasikova M, Dlugosova K, Okruhlicova L, Imanaga I, Ogawa K, Weismann P, Tribulova N (2008) Thyroid hormones suppress epsilon-PKC signalling, down-regulate connexin-43 and increase lethal arrhythmia susceptibility in non-diabetic and diabetic rat hearts. J Physiol Pharmacol 59:271-285 (Pubitemid 351955752)
8. Pappachan JM, Varughese GI, Sriraman R, Arunagirinathan G (2013) Diabetic cardiomyopathy: pathophysiology, diagnostic evaluation and management. World J Diabetes 4:177-189
9. von Schacky C, Harris WS (2007) Cardiovascular risk and the omega-3 index. J Cardiovasc Med 1:46-49
10. London B, Albert Ch, Anderson ME, Giles WR, Van Wagoner DR, Balk E, Billman GE, Chung M, Lands W, Leaf A, McAnulty J, Martens JR, Costello RB, Lathrop DA (2007) Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and their role in Cardiac Arrhythmogenesis Workshop. Circulation 116:320-335
11. De Caterina R (2011) n-3 fatty acids in cardiovascular disease. N Engl J Med 364:2439-2450
12. Zhang M, Picard-Deland E, Marette A (2013) Fish and marine omega-3 polyunsatured fatty acid consumption and incidence of type 2 diabetes: a systematic review and meta-analysis. Int J Endocrinol 2013:1-11
13. Zhukovska AS, Shysh AM, Moibenko OO (2012) Effect of ω-3 polyunsaturated fatty acids on the heart mitochondria respiration in experimental diabetes mellitus. Int J Phys Pathophys 3:363-370
14. Tuncay E, Seymen AA, Tanriverdi E, Yaras N, Tandogan B, Ulusu NN, Turan B (2007) Gender related differential effects of Omega-3E treatment on diabetes-induced left ventricular dysfunction. Mol Cell Biochem 304:255-263 (Pubitemid 47456874)
15. Deckelbaum RJ, Worgall TS, Seo T (2006) n3 Fatty acids and gene expression. Am J Clin Nutr 83:1520-1525
16. Radosinska J, Bacova B, Bernatova I, Navarova J, Zhukovska A, Shysh A, Okruhlicova L, Tribulova N (2011) Myocardial NOS activity and connexin-43 expression in untreated and omega-3 fatty acids-treated spontaneously hypertensive and hereditary hypertriglyceridemic rats. Mol Cell Biochem 347:163-173
17. Radosinska J, Bacova B, Knezl V, Benova T, Zurmanova J, Soukup T, Arnostova P, Slezak J, Gonçalvesova E, Tribulova N (2013) Dietary omega-3 fatty acids attenuate myocardial arrhythmogenic factors and propensity of the heart to lethal arrhythmias in a rodent model of human essential hypertension. J Hypertens 31:1876-1885
18. Mitasikova M, Smidová S, Macsaliová A, Knezl V, Dlugosová K, Okruhlicová L, Weismann P, Tribulová N (2008) Aged male and female spontaneously hypertensive rats benefit from n-3 polyunsaturated fatty acids supplementation. Physiol Res 57:39-48
19. Lambeir AM, Durinx C, Scharpé S, De Meester I (2003) Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40:209-294 (Pubitemid 36775376)
20. Aragno M, Mastrocola R, Ghé C, Arnoletti E, Bassino E, Alloatti G, Muccioli G (2012) Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. Cardiovasc Diabetol 11:1-12
21. Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA (2008) Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 3:1422-1434
22. Weiss JL, Frederiksen JW, Weisfeldt ML (1976) Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 58:751-760
23. Sunagawa K, Maughan WL, Sagawa K (1985) Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res 56:586-595 (Pubitemid 15094777)
24. Takagaki M, McCarthy PM, Chung M, Connor J, Dessoffy R, Ochiai Y, Howard M, Doi K, Kopcak M, Mazgalev TN, Fukamachi K (2002) Preload-adjusted maximal power: a novel index of left ventricular contractility in atrial fibrillation. Heart 88:170-176 (Pubitemid 34787774)
25. Burkhoff D, Mirsky I, Suga H (2005) Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Amer J Physiol Heart Circ Physiol 289:501-512
26. Howarth FC, Chandler NJ, Kharche S, Tellez JO, Greener ID, Yamanushi TT, Billeter R, Boyett MR, Zhang H, Dobrzynski H (2008) Effects of streptozotocin-induced diabetes on connexin43 mRNA and protein expression in ventricular muscle. Mol Cell Biochem 319:105-114
27. Ravingerova T, Neckár J, Kolár F (2003) Ischemic tolerance of rat hearts in acute and chronic phases of experimental diabetes. Mol Cell Biochem 249:167-174 (Pubitemid 37021043)
28. Rauchová H, Vokurková M, Pavelka S, Behuliak M, Tribulová N, Soukup T (2013) N-3 polyunsaturated fatty acids supplementation does not affect changes of lipid metabolism induced in rats by altered thyroid status. Horm Metab Res 45:507-512
29. Khaliq F, Parveen A, Singh S, Gondal R, Hussain ME, Fahim M (2013) Improvement in myocardial function by Terminalia arjuna in Streptozotocin- induced diabetic rats: possible mechanisms. J Cardiovasc Pharmacol Ther 18(5):481-489
30. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, Chien KR, Stuhlmann H, Fishman GI (2001) Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 88:333-339 (Pubitemid 32173758)
31. Gutstein DE, Morley GE, Vaidya D, Liu F, Chen FL, Stuhlmann H, Fishman GI (2001) Heterogeneous expression of Gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation 104:1194-1199 (Pubitemid 32830407)
32. Lampe PD, Lau AF (2004) The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 36:1171-1186 (Pubitemid 38515659)
33. Baum JR, Dolmatova E, Tan A, Duffy HS (2012) Omega 3 fatty acid inhibition of inflammatory cytokine-mediated Connexin43 regulation in the heart. Front Physiol 3:1-8
34. Giger J, Qin AX, Bodell PW, Baldwin KM, Haddad F (2007) Activity of the beta-myosin heavy chain antisense promoter responds to diabetes and hypothyroidism. Am J Physiol Heart Circ Physiol 292:3065-3071
35. Gupta MP (2007) Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J Mol Cell Cardiol 43:388-403
36. Vasudevan NT, Mohan ML, Gupta MK, Martelli EE, Hussain AK, Qin Y, Chandrasekharan UM, Young D, Feldman AM, Sen S, Dorn GW 2nd, Dicorleto PE, Naga Prasad SV (2013) Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction. Circulation 128:377-387
37. Gando S, Hattori Y, Akaishi Y, Nishihira J, Kanno M (1997) Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation. J Pharmacol Exp Ther 282:475-484 (Pubitemid 27425577)